| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |